Factors related to errors in medication prescribing

JAMA

Volumn 277, Issue 4, 1997, Pages 312-317

  Lesar, Timothy S ^a   Briceland, Laurie ^b   Stein, Daniel S ^c  

^a ALBANY MEDICAL CENTER   (United States)

^b ALBANY COLLEGE OF PHARMACY   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; CARDIOVASCULAR AGENT; DIURETIC AGENT; DRUG; GASTROINTESTINAL AGENT; HORMONE DERIVATIVE; MINERAL; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT; VITAMIN; XANTHINE DERIVATIVE;

ARTICLE; CLINICAL PRACTICE; DRUG OVERDOSE; HUMAN; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; MALPRACTICE; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0031030450     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.4.312     Document Type: Article

References (35)

1. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I. N Engl J Med. 1991;324:370-376.
2. Leape LL, Brennan TA, Laird NM, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324:377-384.
3. Bates DW, Cullen DJ, Laird NM, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995; 274:29-34.
4. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse events in hospitalized patients. J Gen Intern Med. 1993;8:289-294.
5. Leape LL, Bates DW, Cullen DJ, et al, for the ADE Prevention Study Group. Systems analysis of adverse drug events. JAMA. 1995;274:35-43.
6. Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape LL. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10:199-205.
7. Folli HL, Poole RL, Benitz WE, Russo JC. Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics. 1987;19:719-722.
8. Lesar TS, Briceland LL, Delcoure K, Crilly Parmalee J, Masta-Gornic V, Pohl H. Medication prescribing errors in a teaching hospital. JAMA. 1990; 263:2329-2334.
9. Leape LL. Error in medicine. JAMA. 1994;272: 1851-1857.
10. Vitillo J, Lesar TS. Preventing medication prescribing errors. DICP. 1991;25:1388-1394.
11. Leape LL. Preventing adverse drug events. Am J Health Syst Pharm. 1995;52:379-382.
12. American Society of Hospital Pharmacists. Draft guidelines on preventable medication errors. Am J Hosp Pharm. 1992;49:640-648.
13. American Medical Association. AMA Board of Trustees Report: Medication (Drug) Errors in Hospitals. Chicago, Ill: American Medical Association; April 1994. Resolution 512, I-93.
14. Potts MS, Phelan KW. Deficiencies on calculation and applied mathematics skills in pediatrics among primary care interns. Arch Pediatr Adolesc Med. 1996;150:748-752.
15. Koren G, Haslam RH. Pediatric medication errors: predicting and preventing tenfold errors. J Clin Pharmacol. 1994;34:1043-1045.
16. Rolfe S, Harper NJN. Ability of hospital doctors to calculate drug doses. BMJ. 1995;310:1173-1174
17. Baldwin L. Calculating drug doses. BMJ. 1995; 310:1154-1155.
18. Lesar TS. Standardized dosing tables to reduce errors involving high-dose methylprednisolone for acute spinal cord injury. Hosp Pharm. 1994;29:935-938.
19. Attilio RM. Caring enough to understand: the road to oncology medication error prevention. Hosp Pharm. 1996;31:17-26.
20. LeBelle MJ. Drug names and medication errors: who is responsible? Can Med Assoc J. 1993; 149:941-943.
21. Landis SJ. Azathioprine or azidothymidine. Can Med Assoc J. 1990;143:611.
22. Lesar TS. Common prescribing errors. Ann Intern Med. 1992;117:537.
23. Davis N. Medical Abbreviations: 5500 Conveniences at the Expense of Communication and Safety. 4th ed. Huntington Valley, Pa: Neil M Davis Assoc; 1987.
24. Kirchbaum DW, Malone PM. Subcutaneous administration of nifedipine. DICP. 1988;22:981-982.
25. Lomaestro BM, Lesar TS, Hagar TP. Errors in prescribing methotrexate. JAMA. 1992;268:2031-2032.
26. Lomaestro BM. More on the GUSTO trial. Ann Intern Med. 1994;121:818-819.
27. Beers MH, Munekata M, Storie M. The accuracy of medication histories in the hospital medical record of elderly persons. J Am Geriatr Soc. 1990; 38:1138-1187.
28. Lesar TS, Briceland LL. Survey of antibiotic control policies in university-affiliated teaching institutions. Ann Pharmacother. 1996;30:31-34.
29. Jick H. Adverse drug reactions in relation to renal function. Am J Med. 1977;62:514-517.
30. Meyersohn MB. Special pharmacokinetic considerations in the elderly. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring. Vancouver, Wash: Applied Therapeutics Inc; 1992:chap 9, pp 1-43.
31. Preston S, Briceland LL, Lomaestro B, Lesar T, Drusano G, Bailie G. Dosing adjustment of 10 antimicrobials for patients with renal impairment. Ann Pharmacother. 1995;29:1205-1208.
32. Bates DW, O'Neil AC, Boyle D, et al. Potential identifiability and preventability of adverse events using information systems. J Am Med Inform Assoc. 1994;1:404-411.
33. Bjornsson DC, Hiner WO, Potyk RP, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm. 1993;50: 1875-1884.
34. McKenney JM, Wasserman AD. Effect of advanced pharmaceutical services on the incidence of adverse drug reactions. Am J Hosp Pharm 1979; 36:1691-1697.
35. Haig GM, Kiser LA. Effect of pharmacist participation on a medical team on costs, charges and length of stay. Am J Hosp Pharm. 1991;48:1457-1462.